- Email: [email protected]
Cumulative subject index for volumes 20–22
GYNECOLOGIC
ONCOLOGY
22, 386400
(1985)
Cumulative Subject Index’ for Volumes 20-22
A
Abstracts Society of Gynecologic Oncologists, Sixteenth Annual Meeting, February 1985,20,247 Actinomycin D, see Dactinomycin Adenocarcinoma cecal neovagina, radiation-induced, case report and literature review, 21, 235 endometrium, with coexisting immature teratoma complicated by gliomatosis peritonei, case report, 21, 106 ovary, advanced, metastatic to brain: spontaneous intracranial hemorrhage, case report, 20, 204 vagina, erroneous diagnosis of prolapsed fallopian tube in postmenopausal patient, case report, 21, 369 Adriamycin and cyclophosphamide and &-platinum combination therapy advanced ovarian cancer patients resistant to chlorambucil and c&platinum, 21, 215 effect on cervical and vaginal cytology, 20, 18
and Cytoxan, cis-diamminedichloroplatinum, and hexamethylmelamine combination therapy: retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 rapid distribution in ascitic and pleural fluid of ovarian carcinoma patients, 21, 65 Age children under 15 years, embryonal ovarian carcinoma and endodermal sinus tumors, clinicopathological case review, 21, 7 postmenopausal women, colposcopy procedures, 20, 62 women over 50 with gestational trophoblastic disease, case reports, 20, 53
Altretamine and Adriamycin, Cytoxan, and cis-diamminedichloroplatinum combination therapy: retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 and cyclophosphamide, and Whtorouracil combination therapy: advanced or recurrent ovarian cancer patients, therapeutic results and toxicity, 20, 23 Announcements Advanced Gynecologic Oncology, Course offered by Vincent Memorial Hospital, Boston, September 1985, 21, 391 Hereditary Gynecologic and Breast Cancer, International Meeting sponsored by Creighton University, Omaha, Nebraska, June 1985, 20, 246 New Certifications by American Board of Obstetrics and Gynecology, Subspecialty of Oncology, 21, 134 Postgraduate Course in Gynecologic and Obstetric Pathology, Harvard Medical School, April 1985, 20, 136 Second International Symposium on Surgery and Biology of Greater Omentum, Royal Society of Medicine, London, April 1986, 22, 383
Seventh Practical Course in Colposcopy and Cervico-Vaginal Histopathology (in English), Paris, September 1985,21,260 Symposium on Exploring the Future of Cancer Care, sponsored by University of Southern California, Pasadena, April 1985, 20, 408 Third Terry Fox Cancer Conference on Cancer Prevention: Theory and Practice, Vancouver, August 1985, 20, 136 Antibodies dissociation from immune complexes extracted
I Boldface numbers indicate appropriate volume; lightface numbers indicate pagination. 386 0090-8258/8.5 $1.50 Copyright AU rights
0 1985 by Academic Press, Inc. of reproduction in any form reserved.
387
SUBJECT INDEX
from ovarian carcinoma ascitic fluid, analysis, 20, 100; erratum, 22, 382 Antigens cancer antigen 125 and carcinoembryonic antigen, ovarian cancer markers, longitudinal study, 21, 1 elevated serum levels prior to epithelial ovarian carcinoma diagnosis, case report, 22, 115 chlamydial and herpesvirus, cell-mediated and humoral immune responses in cervical carcinoma patients, 20, 184 dissociation from immune complexes extracted from ovarian carcinoma ascitic fluid, analysis, 20, 100; erratum, 22, 382 embryonic reactivity with normal placenta, hydatidifonn mole, and gestational choriocarcinoma, comparison, 22, 334 stage-specific, localization in hydatidiform mole, normal placenta, and gestational choriocarcinoma, 20, 71 _ Ascites malignant, cisplatin intraperitoneal administration, clinical pharmacology, 20, 1 ovarian carcinoma, dissociated antibodies and antigens from extracted immune complexes, analysis, 20, 100; erratum, 22, 382 presenting sign in endometrial carcinoma, case reports, 21, 186
Book reviews Carcinoma of the Ovary. H. G. Bender and L. Beck (Eds.), 1983, 20, 245 Silvergirl’s Surgery: The Breast. G. F. Robbins (Ed.), 1984, 22, 381 Brain cerebellar degeneration, paraneoplastic syndrome complication of ovarian cancer, case report and literature review, 21, 240 Bromocriptine cervical carcinoma treatment, phase II trial, 21, 357 C
Cancer, see also specific type cervix lymphatic spread prognosis, and tumor volume and FIG0 classification, relationship, 22, 15 and oral contraceptives, relationship, epidemiologic studies (review), 22, 1 preclinical, diagnosis with colposcopy, cytology, and histology, evaluation, 22, 302 lung, metastatic to ovary, interpretation problems, case reports, 21, 337 ovary advanced cisplatin, 5-fluorouracil, and methotrexate combination chemotherapy after debulking surgery, evaluation, 20, 290 medroxyprogesterone acetate treatment, B phase II trial, 22, 313 and recurrent, treatment with cyclophosBiopsy phamide, hexamethylmelamine, and 5transperineal fine needle, gynecological tumors fluorouracil combination therapy, 20,23 guided by transrectal ultrasound, 22, 281 resistant to chlorambucil and c&platinum, Bleomycin treatment with cyclophosphamide, and actinomycin-D and vinblastine modified Adriamycin, and c&platinum, 21, 215 combination therapy, advanced and recarcinoembryonic antigen and cancer antigen current endodennal sinus tumor patients, 125 levels, longitudinal study, 21, 1 disease behavior and survival rate, differences 20, 336 in various Israeli ethnic groups, 21, 155 and cisplatin epidemiologic trends in heterogeneous popand mitomycinC and vincristine combination ulation, 21, 287 therapy, gynecological squamous cell human cell line Ia 288: characterization, decarcinoma patients, 20, 387 velopment, and growth properties, 20, and vinblastine combination therapy, ovarian endodermal sinus tumor treatment, 20, 92 with paraneoplastic syndrome of cerebellar 162 and methotrexate and cis-platinum combination degeneration, case report and literature review, 21, 240 therapy prior to radiotherapy, effective 2-P-~ribofuranosylthiazole-4-carboxamide treatment of advanced vaginal carcinoma, treatment in murine subrenal capsule case report, 21, 101
388
SUBJECT INDEX
xenograft assay, 21, 351 pelvis, fractured ureteral catheters, case reports, 22, 356 Carbon dioxide laser treatment cervical intraepithelial neoplasia patients case reports, 21, 331; 22, 46 and cryotherapy, comparative efficacy and side effects, 22, 23 Carcinoma, see also specijic type anaplastic, microfocus, coexisting with sarcomalike mural nodules in mutinous ovarian tumor, case report, 20, 219 cervix bromocriptine treatment, phase II trial, 21, 356 combined radiation therapy and radical hysterectomy, complications in patients, 22, 273 epidemiologic patterns, 1926-1%9 and 19701974, comparison, 20, 378 identification of monocyte chemotaxis inhibitor in plasma of untreated patients, 20, 170 invasive, cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens, 20, 184 secondary, metastasis from ovary, colposcopic diagnosis, case report, 21, 124 skeletal metastases, distribution and correlation to clinical stages, 20, 307 squamous cell primary chemotherapy and postoperative adjuvant chemotherapy, case reports, 22, 59 recurrent, presenting as small bowel obstruction, case report, 22, 109 refractory, continuous-infusion vinblastine, phase II trial, 21, 211 Stage IB, pelvic lymph node T-cell proliferative responsiveness, 20, 177 vulvar lymphangioma circumscriptum complication after treatment, case report, 22, 363
Stage IB and IIA, effect of postoperative external radiotherapy, 22, 73 Stage IV, treatment problems, 21, 42 vaginal recurrence after Okabayashi’s radical hysterectomy, case studies, 20, 10 endometrium ascites as presenting sign, case reports, 21, 186 clinically confined to uterus, extrauterine spread, correlation with risk variables, 21, 23
medroxyprogesterone
acetate
high-dose
treatment, effect on fatty acid composition of serum lecithin and cholesterol ester, 22, 317 cauda equina metastatic, secondary compression: neurologic function preservation and survival after surgical decompression and radiotherapy, case report and literature review, 20, 109 peritoneal metastasis, open-field external beam abdominal radiotherapy, 21, 80 plasminogen activator secretion in vitro, indication of tumor aggressiveness, evaluation, 22, 97 premenopausal women, clinicopathological case review, 20, 298 primary Stage I, treatment with hydroxyprogesterone caproate therapy without surgery and radiation therapy, 20, 139 risk factors, epidemiologic and clinical logistic regression analysis, 21, 228; erratum, 22, 133 and second primary malignancy, case reports, 22, 40
Stage I preoperative cesium treatment, evaluation, 20, 325
surgical treatment only, evaluation, 22, 51 Stages Ia and Ib, separate treatment regimes, evaluation, 22, 294 steroid receptor content and response to medroxyprogesterone acetate treatment, correlation, 21, 314 gynecologic, squamous cell: bleomycin, cisplatin, mitomycin-C, and vincristine combination chemotherapy, 20, 387 ovary advanced, cytoreductive surgery: morbidity and mortality assessment, 20, 190 ascitic fluid, dissociated antibodies and antigens from extracted immune complexes, analysis, 20, 100; erratum, 22, 382 ascites and pleural ehitsions, rapid distribution of Adriamycin, 21, 65 embryonal, and endodermal sinus tumors in children under 15 years, clinicopathological case review, 21, 7 endometrioid cis-dichlorodiammine platinum therapy, inappropriate antidiuretic hormone secretion syndrome, case report, 21, 103 pregnancy-related, case report, 21, 364 epithelial, prediagnostic measurement of serum cancer antigen 125 levels, case report, 22, 115 metastatic to cervix, colposcopic diagnosis,
SUBJECT
case report, 21, 124 minimal residual at second-look surgical reassessment, whole abdominal and pelvic irradiation treatment, 20, 271 &-platinum-based combination chemotherapy, antiemetic efficacy of high-dose metoclopramide, 21, 18 recurrent: retreatment with Cytoxan, hexamethylmelamine, Adriamycin, and cisdiamminedichloroplatinum combination therapy after initial complete response to therapy, 21, 167 treatment with Adriamycin, cyclophosphamide, and cis-platinum combination therapy: effect on cervical and vaginal cytology, 20, 78 ’ tumor marker: serum-mediated immunosuppression, 21, 94 vagina advanced squamous: effective treatment with bleomycin, methotrexate, and cis-platinum combination therapy prior to radiotherapy, case report, 21, 101 primary, radiotherapy: various therapy schemes and modes of application, evaluation, 21, 87 primary squamous cell: treatment, complications, and long-term follow-up, 28, 346 recurrent, after Okabayashi’s radical hysterectomy for cervical carcinoma, case studies, 20, 10 vulva advanced, post-radiotherapy lymphangiosarcoma of edematous thigh, case report, 20, 394 with bone metastasis, case reports, 20, 156 neuroendocrine Merkel cell, case report and literature review, 22, 367 prognostic factors: inguinal node status, vascular invasion, and depth of invasion, 20, 364 radical vulvectomy and bilateral groin lymphadenectomy using separate groin incisions, disease recurrence in intervening skin bridge, case report, 21,247 squamous cell metastases, predictive factors, 21, 196 prognostic parameters, evaluation, 22,341 Catheters right atrial, simplified method for insertion, 21, 207 ureteral, fractured, pelvic cancer patients, case reports, 22, 356 CAT scan, see Tomography
INDEX
389
Cauda equina compression secondary to me&static endometrial carcinoma, neurologic function preservation and survival after surgical &compression and radiotherapy, case report and literature review, 20, 109 Cell lines human choriocarcinoma development of methotrexate-resistant subline, 21, 46 invasive potential and role of lytic enzymes, 22, 324 human ovarian cancer (Ia 288), cloned without agar in vitro: characterization, development, and growth properties, 20, 92 human ovarian tumor (OVA-2), heterotransplantation into nude mice, application to treatment of donor patient, 21, 320 Cervical cancer lymphatic spread prognosis, and tumor volume and FIG0 classification, relationship, 22. 15 and oral contraceptives, relationship, epidemiologic studies (review), 22, 1 preclinical: diagnosis with colposcopy, cytology, and histology, evaluation, 22, 302 Cervical carcinoma bromocriptine treatment, phase II trial, 21,356 combined radiation therapy and radical hysterectomy, complications, case reports, 22, 273 epidemiologic patterns, 1926-1969 and 19701974, comparison, 20, 378 identification of monocyte chemotaxis inhibitor in plasma of untreated patients, 20, 170 invasive, cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens, 20, 184 Okabayashi’s radical hysterectomy, subsequent vaginal recurrence, case studies, 20, 10 secondary, metastasis from ovary, colposcopic diagnosis, case report, 21, 124 skeletal metastases, distribution and correlation to clinical stages, 20, 307 squamous cell primary chemotherapy and postoperative adjuvant chemotherapy, case reports, 22, 59 recurrent, presenting as small bowel obstruction, case report, 22, 109 refractory, continuous-infusion vinblastine, phase II trial, 21, 211 Stage IB, pelvic lymph node T-cell proliferative responsiveness, 20, 177
390
SUBJECT INDEX
vulvar lymphangioma circumscriptum comand methotrexate and cis-platinum: prior to plication after treatment, case report, 22, radiotherapy, effective treatment of ad363 vanced vaginal carcinoma, case report, Stage IB and IIA, effect of postoperative ex21, 101 ternal radiotherapy, 22, 73 bromocriptine phase II trial, cervical carcinoma Stage IV, treatment problems, 21, 42 patients, 21, 356 Cerviscope cisplatin, 5-fluorouracil, and methotrexate: adas mass screening tool for high-risk populations, vanced ovarian cancer patients after deevaluation, 20, 17 bulking surgery, evaluation, 20, 290 Cervix cyclophosphamide, hexamethylmelamine, and dysplasia, mild or moderate: topical vaginal Nluorouracil: advanced and recurrent retinyl acetate gel administration, phase ovarian cancer, therapeutic results and I-II clinical trial, 20, 109 toxicity, 20, 23 glial polyp, immunoperoxidase location of glial cis-dichlorodiammine platinum, ovarian carfibrillary acidic protein, case report, 21, cinoma patient, inappropriate antidiuretic 385 hormone secretion syndrome, case reintraepithelial neoplasia port, 21, 103 carbon dioxide laser treatment, case reports, experimental, human ovarian tumor line het21, 331; 22, 46 erotransplanted into nude mice, applicell-mediated and humoral immune responses cation to treatment of donor patient, 21, to chlamdial and herpesvims antigens, 320 20, 184 c&platinum cryotherapy and laser vaporization treatment, -based combination, antiemetic efficacy of comparative efficacy and side effects, high-dose metoclopramide, 21, 18 -induced emesis, reduction with methylpred22, 23 stromal sarcoma confined to polyp, case report, nisolone and/or metoclopramide, com22, 10s parison, 21, 306 Cesium primary therapy and postoperative adjuvant preoperative, Stage I endometrial carcinoma therapy, squamous cell cervical carcipatients, evaluation, 20, 325 noma patients, case reports, 22, 59 and radiotherapy, recurrent ovarian mixed meChemotherapy sodermal sarcoma, case report, 22, 129 actinomycin-D, bleomycin, and vinblastine: 2-p-n-ribofuranosylthiazole-4-carboxamide acadvanced and recurrent ovarian endotion against human ovarian cancers in dermal sinus tumor patients, 20, 336 murine subrenal capsule xenograft assay, adjuvant, and/or postoperative adjuvant radio21, 351 therapy, evaluation in treatment of uterChlamydia trachomatis ine sarcomas, 20, 281 antigens, cell-mediated and humoral immune Adriamycin responses in cervical carcinoma patients, and cyclophosphamide and &-platinum 20, 184 advanced ovarian cancer patients resistant to chlorambucil and c&platinum treat- Chlorambucil ment, 21, 215 and cis-platinum combination therapy, resistant ovarian carcinoma patients, effect on advanced ovarian cancer patients, subcervical and vaginal cytology, 20, 78 sequent treatment with cyclophosphaand Cytoxan, cis-diamminedichloroplatinum, mide, Adriamycin, and cis-platinum, 21, and hexamethylmelamine: retreatment of 215 recurrent ovarian carcinoma after initial Choriocarcinoma complete response to therapy, 21, 167 colonic pseudoobstruction, evaluation and rapid distribution in ascitic and pleural fluid nonsurgical management, case report, 20, of ovarian carcinoma patients, 21, 65 402 bleomycin gestational and cisplatin, mitomycin-C, and vincristine: localization of stage-specific embryonic angynecological squamous cell carcinoma tigens, comparison with hydatidiform patients, 20, 387 mole and normal placenta, 20, 71
391
SUBJECT INDEX
and normal placenta and hydatidiform mole: reactivity to anti-human sperm monoclonal antibodies, comparison, 22, 334 human cell line development of methotrexate-resistant subline, 21, 46 invasive potential and role of lytic enzymes, 22, 324 Cisplatin and Adriamycin, Cytoxan, and hexamethylmelamine combination therapy: retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 and bleomycin and mitomycin-C and vincristine combination therapy, gynecological squamous cell carcinoma patients, 20, 387 and vinblastine combination therapy, ovarian endodermal sinus tumor treatment, 20, 162 and 5-fluorouracil and methotrexate combination therapy, advanced ovarian cancer patients after debulking surgery, 20, 290 intraperitoneal administration to patients with malignant ascites, clinical pharmacology, 20, 1 Collagenase role in invasive potential of human choriocarcinema cell lines, 22, 324 colposcopy diagnosis of ovarian carcinoma metastatic to cervic, case report, 21, 124 diagnostic value, preclinical cervical cancer patients, 22, 302 diethylstilbestrol-exposed young women, pathologic correlation, 21, 277 procedures for postmenopausal women, 20,62 Cryotherapy and laser vaporization, comparative efficacy and side effects, cervical intraepithelial neoplasia patients, 22, 23 Cyclophosphamide and Adriamycin and cis-diamminedichloroplatinum and hexamethylmelamine combination therapy, retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 and c&platinum combination therapy advanced ovarian cancer patients resistant to chlorambucil and cis-platinum, 21,215 effect on cervical and vaginal cytology, 20, 78
and hexamethylmelamine and Sfluorouracil combination therapy, advanced or recurrent ovarian cancer patients, therapeutic results and toxicity, 20, 23 Cytology cervical and vaginal, ovarian carcinoma patients: effect of Adriamycin, cyclophosphamide, and c&platinum combination therapy, 20, 78 diagnostic value, preclinical cervical cancer patients, 22, 302 Cytoxan, see Cyclophosphamide D
Dactinomycin and bleomycin and vinblastine modified combination therapy, advanced and recurrent endodermal sinus tumor patients, 20, 336 DES, see Diethylstilbestrol cis-Diamminedichloroplatinum, see Cisplatin cis-Dichlorodiammine platinum therapy for ovarian carcinoma patient, inappropriate antidiuretic hormone secretion syndrome, case report, 21, 103 Diethylstilbestrol -exposed young women, pathology of colposcopic findings, 21, 277 7,12-Dimethylbenzhrlanthracene, see 9,10-Dimethyl-l ,2-benzanthracene 9, IO-Dimethyl- 1,Zbenzanthracene -induced ovarian tumors in rats by direct application, 21, 54 Doxorubicin, see Adriamycin Dysgerminoma pure, with elevated serum human chorionic gonadotropin levels, case report and literature review, 20, 234 serum lactic dehydrogenase levels and isoenzyme analysis, prognostic value, 22, 65 Dysplasia cervix, mild or moderate: topical vaginal retinyl acetate gel administration, phase I-II clinical trial, 20, 109 E
Emesis c&platinum-induced, reduction with methylprednisolone and/or metoclopramide, comparison, 21, 306 Endometrial adenocarcinoma with coexisting immature teratoma complicated
392
SUBJECT INDEX
by gliomatosis peritonei, case report, 21, 106 Endometrial carcinoma ascites as presenting sign, case reports, 21, 186 chicalIy confined to uterus, extrauterine spread, correlation with risk variables, 21, 23 medroxyprogesterone acetate high-dose treatment, effect on fatty acid composition of serum lecithin and cholesterol ester, 22, 317 metastatic, secondary cauda equina compression: neurologic function preservation and survival after surgical decompression and radiotherapy, case report and literature review, 20, 109 peritoneal metastasis, open-field external beam abdominal radiotherapy, 21, 80 plasminogen activator secretion in vitro: indication of tumor aggressiveness, evaluation, 22, 97 premenopausal women, clinicopathological case review, 20, 298 primary Stage I, treatment with hydroxyprogesterone caproate therapy without surgery and radiation therapy, 20, 139 risk factors, epidemiologic and clinical logistic regression analysis, 21, 228; erratum, 22, 133 and second primary malignancy, case reports, 22, 40 Stage I preoperative cesium treatment, evaluation, 20, 325 surgical treatment only, evaluation, 22, 51 Stages Ia and Ib, separate treatment regimes, evaluation, 22, 294 steroid receptor content and response to medroxyprogesterone acetate treatment, correlation, 21, 314 Endometrial sarcoma association with ovarian thecoma, polycystic ovarian disease, and prolonged estrogen therapy, 21, 135 Estradiol-17/3 effect on myometrium and leiomyoma cultured smooth muscle cell differentiation, ultrastructural analysis, 21, 32 Estrogen elevated serum levels, ovarian Sertoli cell tumor patient, case report, 22, 85 precolposcopic administration for postmenopausal women, 20, 62 prolonged therapy, and ovarian thecoma and polycystic ovarian disease: association with endometrial sarcomas, 21, 135
Estrogen receptors nuclear, high levels in solitary pelvic neural tumors, case reports, 20, 43 identification in recurrent and metastatic endolymphatic stromal myosis patient with good response to progestin therapy, case report, 20, 120 tumor content, and response to medroxyprogesterone acetate treatment, correlation, endometrial carcinoma patients, 21,314 Ethnicity population differences in ovarian cancer in Israel, 21, 155, 287 F
Fallopian tube prolapse, misdiagnosis as vaginal adenocarcinoma in postmenopausal patient, case report, 21, 369 Fatty acids in serum lecithin and cholesterol ester, effect of high-dose medroxyprogesterone acetate, endometrial carcinoma patients, 22, 317 o-Fetoprotein in ovarian immature teratoma, heterogenous origin, immunocytochemical evidence, 21, 73
FIG0 classification role in prognosis of lymphatic spread from cervical cancer, comparison with tumor volume, 22, 15 Fistulae ureterovaginal, after radical hysterectomy, effect of internal iliac artery ligation, 21, 359 5-Fluorouracil and cisplatin and methotrexate combination therapy, advanced ovarian cancer patients after debulking surgery, 20, 290 and cyclophosphamide and hexamethylmelamine combination therapy, advanced or recurrent ovarian cancer patients, therapeutic results and toxicity, 20, 23 Formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide -induced ovarian tumors in rats by direct application, 21, 54 G Gastrointestinal tract site of recurrent squamous cell cervical carcmoma, case report, 22, 109
SUBJECT
Glioma in cervix, immunoperoxidase location of glial fibrillary acidic protein, case report, 21, 385 Gliomatosis peritonei complication in coexistent immature teratoma and endometrial adenocarcinoma, case report, 21, 106 Gonadotropin human chorionic, see Human chorionic gonadotropin H
Hemangiopericytoma vaginal, light and electron microscopy, case report, 21, 376 Herpes simplex virus antigens, cell-mediated and humoral immune responses in cervical carcinoma patients, 20, 184 Hexamethylmelamine, see Altretamine Histology diagnostic value, preclinical cervical cancer patients, 22, 302 Hormones, see also specific hormones antidiuretic, inappropriate secretion syndrome during cis-dichlorodiammine platinum therapy, ovarian carcinoma patient, case report, 21, 103 Human chorionic gonadotropin P-subunit, elevated serum levels in association with pure dysgenninoma, case report and literature review, 20, 234 Hydatidiform mole and gestational choriocarcinoma and normal placenta, reactivity to anti-human sperm monoclonal antibodies, comparison, 22, 334
localization of stage-specific embryonic antigens, comparison with normal placenta and gestational choriocarcinoma, 20, 71 Hydroxyprogesterone caproate treatment for primary endometrial carcinoma Stage I, 20, 139 Hysterectomy Okabayashi’s radical, cervical carcinoma treatment, subsequent vaginal recurrence, case studies, 20, 10 radical with lymph node dissection, lower urinary tract changes: dynamic videourethrocystography and simultaneous urethrocystometry, 21, 261
393
INDEX
postoperative ureterovaginal fistula, effect of internal iliac artery ligation, 21, 359 and radiation therapy, cervical carcinoma patients, complications, case reports, 22, 273
Immune responses cell-mediated and humoral, to chlamydial and herpesvirus antigens, cervical carcinoma patients, 20, 184 Immunosuppression normal in vitro T-cell proliferation and natural killer cell activity, by serum from ovarian carcinoma patients, 21, 94 Intestinal obstruction colonic pseudoobstruction, choriocarcinoma patient, evaluation and nonsurgical management, case report, 20, 402 Irradiation -induced adenocarcinoma in cecal neovagina, case report and literature review, 21, 235
whole abdominal and pelvic, ovarian carcinoma patients with minimal residual disease at second-look surgical reassessment, 20, 271 K
Keratoacanthoma vulva, case report, 21, 118 L
Lactic dehydrogenase serum levels and isoenzyme analysis: ovarian tumor marker, evaluation, 22, 65 Leiomyosarcoma uterine, clinicopathologic case studies, 21, 220 Lung cancer metastatic to ovary, interpretation problems, case reports, 21, 337 Lymphangioma circumscriptum vulvar, post-treatment complication, squamous cell cervical carcinoma patient, case report, 22, 363 Lymphangiosarcoma edematous thigh, post-radiotherapy development in vulvar carcinoma patient, case report, 20, 394 Lymph node pelvic, cervical squamous cell carcinoma pa-
394
SUBJECT
tients, T-cell proliferative responsiveness, 20, 177 Lymphocytes T-cell proliferation and natural killer cell activity in vitro, suppressive effect of serum from ovarian carcinoma patients, 21, 94 M
Malignancies, see also specific types gynecologic, surgical technique for abdominal retroperitoneum exploration, 22, 32 multiple primaries, endometrial carcinoma patients, case reports, 22, 40 ovary, treatment with intraperitoneal phosphorus-32, safety and morbidity evaluation, 21, 294 Medroxyprogesterone acetate advanced ovarian cancer treatment, phase II trial, 22, 313 effect on plasminogen activator activity in human endometrial carcinoma explants, 22, 97 endometrial carcinoma patient response, correlation with steroid receptor content, 21, 314 high-dose, effect on fatty acid composition of serum lecithin and cholesterol ester in endometrial carcinoma patients, 22, 317 Merkel cell carcinoma vulva, case report and literature review, 22, 367 Metastasis bony from cervical carcinoma, distribution and correlation to clinical stages, 20, 307 from vulvar carcinoma, case reports, 20, 156 brain, from advanced ovarian adenocarcinoma: spontaneous intracranial hemorrhage, case report, 20, 204 cervical, from ovarian carcinoma, colposcopic diagnosis, case report, 21, 124 inguinal, from vulva squamous cell carcinoma, predictive factors, 21, 196 lymphatic, and tumor volume and FIG0 classification, relationship in cervical cancer prognosis, 22, 15 ovarian, from lung cancer, interpretation problems, case reports, 21, 337 peritoneal, from endometrial carcinoma patients, open-field external beam abdominal radiotherapy, 21, 80 placental-site trophoblastic tumor: failure of chemotherapy, surgery, and radiotherapy, case report, 21, 111
INDEX
renal, from malignant gestational trophoblastic disease, use of intravenous urography in staging, 20, 317 Methotrexate and bleomycin and &-platinum combination therapy prior to radiotherapy, effective treatment of advanced vaginal carcinoma, case report, 21, 101 and cisplatin and Sfluorouracil combination therapy, advanced ovarian cancer patients after debulking surgery, 20, 290 -resistant human choriocarcinoma cell line, development, 21, 46 N-Methyl-N’nitrosourea -induced ovarian tumors in rats by direct application, 21, 54 Methylprednisolone and/or metoclopramide, comparative efficacy in reduction of cis-platinum-induced emesis, 21, 306 Metoclopramide high-dose, antiemetic in patients receiving cisplatinum-based combination chemotherapy, 21, 18 and/or methylprenisolone, comparative efficacy in reduction of c&platinum-induced emesis, 21, 306 Mitomycin C and bleomycin, cisplatin, and vincristine combination therapy, gynecological squamous cell carcinoma patients, 20, 387 Monocytes chemotaxis, inhibitor identification in plasma of untreated cervical carcinoma patients, 20, 170 Morphine postoperative pain relief, continuous intravenous infusion and intramuscular injections, comparison, 22, 288 Myoblastoma granular cell, vulvar involvement, case reports, 22, 352 N
Neoplasia intraepithelial cervix carbon dioxide laser treatment, case reports, 21, 331; 22, 46 cell-mediated and humoral immune responses to chlamdial and herpesvirus antigens, 20, 184 cryotherapy and laser vaporization treatment, comparative efficacy and side effects, 22, 23
SUBJECT INDEX
395
treatment in murine subrenal capsule xenograft assay, 21, 351 Ovarian carcinoma advanced, cytoreductive surgery, morbidity and mortality assessment, 20, 190 ascites and pleural effisions, rapid distribution of Adriamycin, 21, 65 ascitic fluid, dissociated antibodies and antigens from extracted immune complexes, analysis, 20, 100; erratum, 22, 382 embryo@ and endodermal sinus tumors in children under 15 years, clinicopathological case review, 21, 7 endometrioid cis-dichlorodiammine platinum therapy, inappropriate antidiuretic hormone secreation syndrome, case report, 21, 103 pregnancy-related, case report, 21, 364 epithelial, prediagnostic measurement of serum 0 cancer antigen 125 levels, case report, 22, 115 Oral contraceptives metastatic to cervix, colposcopic diagnosis, case and cervical cancer, relationship, epidemiologic report, 21, 124 studies (review), 22, 1 minimal residual at second-look surgical reasOvarian adenocarcinoma sessment, whole abdominal and pelvic advanced, metastatic to brain: spontaneous inirradiation treatment, 20, 271 tracranial hemorrhage, case report, 20, cis-platinum-based combination chemotherapy, 204 antiemetic efficacy of high-dose metoOvarian cancer clopramide, 21, 18 advanced recurrent, retreatment with Cytoxan, hexacisplatin, Muorouracil, and methotrexate methylmelamine, Adriamycin, and ciscombination chemotherapy after dediamminedichloroplatinum combination bulking surgery, evaluation, 20, 290 therapy after initial complete response medroxyprogesterone acetate treatment, to therapy, 21, 167 phase II trial, 22, 313 treatment with Adriamycin, cyclophosphamide, and recurrent, treatment with cyclophosand cis-platinum combination therapy: phamide, hexamethylmelamine, and 5effect on cervical and vaginal cytology, fluorouracil combination therapy, 20,23 20, 78 tumor marker: serum-mediated immunoresistant to chlorambucil and cis-platinum, with treatment cyclophosphamide, suppression, 21, 94 Adriamycin, and c&platinum, 21, 215 ovary carcinoembryonic antigen and cancer antigen bilateral teratomas, coexistence with sclerosing 125 levels, longitudinal study, 21, 1 stromal tumor, case report, 21, 252 disease behavior and survival rate, differences dysgerminoma in various Israeli ethnic groups, 21, 155 elevated serum human chorionic gonadotropin epidemiologic trends in heterogeneous populevels, case report and literature review, lation, 21, 287 20, 234 human cell line Ia 288: characterization, deserum lactic dehydrogenase levels and isovelopment, and growth properties, 20, enzyme analysis, prognostic value, 22, 65 92 endodermal sinus tumor with paraneoplastic syndrome of cerebellar deadvanced and recurrent: modified vinblastine, generation, case report and literature review, 21, 240 actinomycin-D, and bleomycin combi2-p-u-ribofuranosylthiazole-4-carboxamide nation therapy, 20, 336 vulva, treatment by local excision and colposcopy efficacy, retrospective evaluation, 21, 300 Neoplasms, see also specific neoplasms endolymphatic stromal myosis, recurrent and metastatic: positive estrogen and progesterone receptors and good response to progestin therapy, case report, 20, 120 epithelial ovarian, of low malignant potential, case reports, 21, 177 Neovagina cecal, radiation-induced adenocarcinoma, case report and literature review, 21, 235 Nodules mural, sarcoma-like, coexisting with microfocus of anaplastic carcinoma in mutinous ovarian tumor, case report, 20, 219
396
SUBJECT INDEX
treatment with cisplatin, vinblastine, and localization of stage-specific embryonic antigens, comparison with hydatidiform bleomycin combination therapy, 20, 162 mole and gestational choriocarcinoma, epitheliti neoplasms of low malignant potential, 20, 71 case reports, 21, 177 immature teratoma, heterogenous origin of o- Plasma monocyte chemotaxis inhibitor, identification fetoprotein, immunocytochemical eviin untreated cervical carcinoma patients, dence, 21, 73 malignancies, treatment with intraperitoneal 20, 170 Plasminogen activator phosphorus-32, safety and morbidity secretion by human endometrial carcinoma exevaluation, 21, 294 mixed mesodermal sarcoma, recurrent, survival plants: indication of tumor aggressiveafter combination radiotherapy and ness, evaluation, 22, 97 &-Platinum chemotherapy, 22, 129 and Adriamycin and cyclophosphamide comthecoma, polycystic disease, and prolonged esbination therapy trogen therapy: association with endoadvanced ovarian cancer patients resistant metrial sarcomas, 21, 135 tumors to chlorambucil and &-platinum, 21, 215 effect on cervical and vaginal cytology, 20, cell line OVA-2, heterotransplantation into 78 nude mice, application to treatment of -based combination chemotherapy, antiemetic donor patient, 21, 320 chemical induction in rats, 21, 54 efficacy of high-dose metoclopramide in patients with advanced malignancies, 21, metastatic, from lung cancer, interpretation 18 problems, case reports, 21, 337 and bleomycin and methotrexate combination mutinous, with sarcoma-like mural nodules therapy prior to radiotherapy, effective coexisting with microfocus of anaplastic treatment of advanced vaginal carcinoma, carcinoma, case report, 20, 219 case report, 21, 101 Sertoli cell, elevated serum estrogen and -induced emesis, reduction with methylpredprogesterone levels, case report, 22, 85 nisolone and/or metoclopramide, comstrumal carcinoid, with amyloid stroma, case parison, 21, 306 report and 20-year follow-up, 22, 121 primary chemotherapy and postoperative adjuvant chemotherapy, squamous cell P cervical carcinoma patients, case reports, 22, 59 Paraneoplastic syndrome Polycystic ovarian disease cerebellar degeneration, ovarian cancer patient, and ovarian thecoma and prolonged estrogen case report and literature review, 21, therapy, association with endometrial 240 sarcomas, 21, 135 Pelvic cancer Pregnancy fractured ureteral catheters, case reports, 22, -related ovarian endometrioid carcinoma, case 356 report, 21, 364 Pelvis Progesterone solitary benign neural tumors with high steroid effect on myometrium and leiomyoma cultured receptor content, case reports, 20, 43 smooth muscle cell differentiation, ulPhosphorus-32 trastructural analysis, 21, 32 intraperitoneal instillation, ovarian malignancy elevated serum levels, ovarian Sertoli cell tumor treatment, safety and morbidity evalupatient, case report, 22, 85 ation, 21, 294 Progesterone receptors Placenta identification in recurrent and metastatic ennormal dolymphatic stromal myosis patient with and gestational choriocarcinoma and hydagood response to progestin therapy, case tidiform mole: reactivity to anti-human report, 20, 120 sperm monoclonal antibodies, compartumor content, and response to medroxyproison, 22, 334 gesterone acetate treatment, correlation,
SUBJECT INDEX endometrial carcinoma patients, 21, 314 Progestin receptors cytoplasmic and nuclear, high levels in solitary pelvic neural tumors, case reports, 20, 43 Progestin therapy, see also Medroxyprogesterone acetate recurrent and metastatic endolymphatic stromal myosis patient with good response, case report, 20, 120 Proteins glial fibrillary acidic, immunoperoxidase location in cervical glial polyp, case report, 21, 385
397
action against untreated human ovarian cancers in murine subrenal capsule xenograft assay, 21, 351
S
Sarcoma dermatofibrosarcoma protuberans, vulva, case report, 20, 129 endometrial, association with ovarian thecoma, polycystic ovarian disease, and prolonged estrogen therapy, 21, 135 leiomyosarcoma, see Leiomyosarcoma -like mural nodules, coexisting with microfocus of anaplastic carcinoma in mutinous R ovarian tumor, case report, 20, 219 mixed mesodenual, ovarian, recurrent: survival after combination radiotherapy and Radiation therapy, see Radiotherapy chemotherapy, 22, 129 Radiotherapy stromal, in cervical polyp, case report, 22, 105 abdominal, open-field external beam, endometrial carcinoma patients with peritouterine adjuvant radiotherapy and/or chemotherapy, neal metastases, 21, 80 evaluation, 20, 281 and chemotherapy, recurrent ovarian mixed epidemiology and clinical course, Israeli 7mesodermal sarcoma, case report, 22, year study, 20, 354; letter to editor, 22, 129 379 with intraperitoneal phosphorus-32, safety and Sertoli cell tumor morbidity evaluation, ovarian malignancy ovarian, elevated serum estrogen and progespatients, 21, 294 terone levels, case report, 22, 85 postoperative Stein-Leventhal syndrome, see Polycystic ovarian adjuvant, and/or adjuvant chemotherapy, disease evaluation in treatment of uterine sarSurgery comas, 20, 281 abdominal retroperitoneum exploration techeffect on cervical carcinoma Stage IB and nique, use in staging of gynecologic maIIA, 22, 73 and radical hysterectomy, cervical carcinoma lignancy patients, 22, 32 patients, complications, case reports, 22, cytoreductive, advanced ovarian carcinoma patients, morbidity and mortality as273 various therapy schemes and modes of applisessment, 20, 190 cation, effect on remission rates for prihysterectomy, see Hysterectomy mary vaginal carcinoma patients, 21, 87 ligation of internal iliac artery during radical and vertebrectomy for cauda equina compreshysterectomy, effect on urinary tract fission secondary to metastatic endometrial tula formation, 21, 359 carcinoma, neurologic function preserpostoperative pain relief with morphine, continuous intravenous infusion and intravation and survival, case report and litmuscular injections, comparison, 22,288 erature review, 20, 209 vulvar carcinoma patient, post-treatment deradical vulvectomy and bilateral groin lymphadenectomy using separate groin incivelopment of lymphangiosarcoma of sions, vulvar carcinoma recurrence in edematous thigh, case report, 20, 394 Retinyl acetate intervening skin bridge, case report, 21, gel, topical vaginal administration to mild or 247 moderate cervical dysplasia patients, Stage I endometrial carcinoma treatment, comparison with combined surgery and irphase I-II clinical trial, 20, 109 2-fl-r&ibofuranosylthiazole-4-carboxamide radiation therapy, 22, 51
398
SUBJECT INDEX
vertebrectomy for cauda equina compression secondary to metastatic endometrial carcinoma, neurologic function preservation and survival, case report and literature review, 20, 209 T
T cells pelvic lymph node, isolated from cervical squamous cell carcinoma patients: numbers and reactivities, 20, 177 Teratoma bilateral, ovarian, coexistence with sclerosing stromal tumor, case report, 21, 252 immature coexistence with endometrial adenocarcinoma complicated by gliomatosis peritonei, case report, 21, 106 ovarian, heterogenous origin of a-fetoprotein, immunocytochemical evidence, 21, 73 Thrombosis deep venous, prevention with Venodyne or leg compressors, letter to editor, 21, 133 Tiazofurin, see 2-p-o-Ribofuranosylthiazole-4carboxamide Tomography computed, and ultrasonography, use in primary diagnosis of gynecological tumors, 21, 161 Trophoblastic disease gestational late recurrence, case reports, 20, 83 malignant with renal metastases, use of intravenous urography in staging, 20, 317 in women aged 50 or more, case reports, 20, 53 Trophoblasts normal placental, and gestational choriocarcinoma and hydatidiform mole: reactivity to anti-human sperm monoclonal antibodies, comparison, 22, 334 Tumors, see also speciJc tumors endodermal sinus infant vagina, case report, 20, 196 and ovarian embryonal carcinoma, in children under 1.5years, clinicopathological case review, 21, 7 ovary advanced and recurrent: modified vinblastine, actinomycin-D, and bleomycin combination therapy, 20, 336 treatment with cisplatin, vinblastine, and bleomycin combination therapy, 20, 162
gynecologic primary diagnosis by ultrasonography and computed tomography, 21, 161 transperineal fine needle biopsy guided by transrectal ultrasound, 22, 281 hemangiopericytoma, vaginal, light and electron microscopy, case report, 21, 376 keratoacanthoma, vulvar, case report, 21, 118 leiomyoma, and myometrium cultured smooth muscle cell differentiation, sex steroid effect, ultrastructural analysis, 21, 32 malignancy evaluation by mitotic count, letter to editor, 22, 379 malignant mesodermal mixed, uterus: prognostic factors, surgicopathologic stage, and vascular invasion, 20, 32 neural, solitary benign, pelvis: with high steroid receptor content, case reports, 20, 43 ovarian cell line OVA-2, heterotransplantation into nude mice, application to treatment of donor patient, 21, 320 metastatic from lung cancer, interpretation problems, case reports, 21, 337 chemical induction in rats, 21, 54 mutinous, with sarcoma-like mural nodules coexisting with microfocus of anaplastic carcinoma, case report, 20, 219 strumal carcinoid with amyloid stroma, case report and 20-year follow-up, 22, 121 thecoma, and polycystic ovarian disease and prolonged estrogen therapy: association with endometrial sarcomas, 21, 135 sclerosing stromal, coexistence with bilateral teratomas, case report, 21, 252 trophoblastic pseudotumor, metastatic: failure of chemotherapy, surgery, and radiotherapy, case report, 21, 111 Tumor volume role in prognosis of lymphatic spread from cervical cancer, comparison with pathological staging, 22, 15
U
Ultrasonography and computed tomography, use in primary diagnosis of gynecological tumors, 21, 161 Ultrasound transrectal, -guided transperineal fine needle biopsy of gynecological tumors, 22, 281 Urethrocystography and urethrocystometry, simultaneous urody-
399
SUBJECT INDEX
namic evaluation of lower urinary tract changes after radical hysterectomy with lymph node dissection, 21, 261 Urethrocystometry and urethrocystography, simultanous urodynamic evaluation of lower urinary tract changes after radical hysterectomy with lymph node dissection, 21, 261 Urinary tract fistula formation after radical hysterectomy, effect of internal iliac artery ligation, 21, 3.59
lower, changes after radical hysterectomy with lymph node dissection, dynamic videourethrocystography and simultaneous urethrocystometry, 21, 261 Urography intravenous, use in staging of malignant gestational trophoblastic disease with renal metastases, 20, 317 Uterus cervix, see Cervix coexistent immature teratoma and endometrial adenocarcinoma complicated by gliomatosis peritonei, case report, 21, 106 extrauterine spread in endometrial carcinoma clinically confined to uterus, correlation with risk variables, 21, 23 leiomyoma and myometrium, cultured smooth muscle cell differentiation, sex steroid effect, ultrastructural analysis, 21, 32 leiomyosarcoma, clinicopathologic case studies, 21, 220
malignant mesodermal mixed tumors: prognostic factors, surgicopathologic stage, and vascular invasion, 20, 32 placental-site trophoblastic tumor, metastatic: failure of chemotherapy, surgery, and radiotherapy, case report, 21, 111 sarcoma adjuvant radiotherapy and/or chemotherapy, evaluation, 20, 281 epidemiology and clinical course, Israeli 7year study, 20, 354; letter to editor, 22, 379
V
Vagina, see also Neovagina endodermal sinus tumor, infant, case report, 20, 1% hemangiopericytoma, light and electron mi-
croscopy, case report, 21, 376 Vaginal adenocarcinoma erroneous diagnosis of prolapsed fallopian tube in postmenopausal patient, case report, 21, 369
Vaginal carcinoma advanced squamous, effective treatment with bleomycin, methotrexate, and cis-platinum combination therapy prior to radiotherapy, case report, 21, 101 primary, radiotherapy: various therapy schemes and modes of application, evaluation, 21, a7
recurrent, after Okabayashi’s radical hysterectomy for cervical carcinoma, case studies, 20, 10 squamous cell: treatment, complications, and long-term follow-up, 20, 346 Vinblastine and actinomycin-D and bleomycin modified combination therapy, advanced and recurrent endodermal sinus tumor patients, 20, 336
and bleomycin and cisplatin combination therapy, ovarian endodermal sinus tumor treatment, 20, 162 continuous infusion, refractory cervical squamous cell carcinoma treatment, phase II trial, 21, 211 Vincristine and bleomycin, cisplatin, and mitomycin-C combination therapy, gynecological squamous cell carcinoma patients, 20, 387
Vulva dermatofibrosarcoma protuberans, case report, 20, 129
granular cell myoblastoma, case reports, 22, 352
intraepithelial neoplasia, treatment by local excision and colposcopy efficacy, retrospective evaluation, 21, 300 keratoacanthoma, case report, 21, 118 lymphangioma circumscriptum, post-treatment complication, squamous cell cervical carcinoma patient, case report, 22, 363 neuroendocrine carcinoma, case report and literature review, 22, 367 Vulvar carcinoma advanced, post-radiotherapy lymphangiosarcoma of edematous thigh, case report, 20, 394
with bone metastasis, case reports, 20, 156 prognostic factors: inguinal node status, vascular
400
SUBJECT
invasion, and depth of invasion, 20, 364 radical vulvectomy and bilateral groin lymphadenectomy using separate groin incisions, disease recurrence in intervening
INDEX
skin bridge, case report, 21, 241 squamous cell metastases, predictive factors, 21, 196 prognostic parameters, evaluation, 22, 341
ONCOLOGY
22, 386400
(1985)
Cumulative Subject Index’ for Volumes 20-22
A
Abstracts Society of Gynecologic Oncologists, Sixteenth Annual Meeting, February 1985,20,247 Actinomycin D, see Dactinomycin Adenocarcinoma cecal neovagina, radiation-induced, case report and literature review, 21, 235 endometrium, with coexisting immature teratoma complicated by gliomatosis peritonei, case report, 21, 106 ovary, advanced, metastatic to brain: spontaneous intracranial hemorrhage, case report, 20, 204 vagina, erroneous diagnosis of prolapsed fallopian tube in postmenopausal patient, case report, 21, 369 Adriamycin and cyclophosphamide and &-platinum combination therapy advanced ovarian cancer patients resistant to chlorambucil and c&platinum, 21, 215 effect on cervical and vaginal cytology, 20, 18
and Cytoxan, cis-diamminedichloroplatinum, and hexamethylmelamine combination therapy: retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 rapid distribution in ascitic and pleural fluid of ovarian carcinoma patients, 21, 65 Age children under 15 years, embryonal ovarian carcinoma and endodermal sinus tumors, clinicopathological case review, 21, 7 postmenopausal women, colposcopy procedures, 20, 62 women over 50 with gestational trophoblastic disease, case reports, 20, 53
Altretamine and Adriamycin, Cytoxan, and cis-diamminedichloroplatinum combination therapy: retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 and cyclophosphamide, and Whtorouracil combination therapy: advanced or recurrent ovarian cancer patients, therapeutic results and toxicity, 20, 23 Announcements Advanced Gynecologic Oncology, Course offered by Vincent Memorial Hospital, Boston, September 1985, 21, 391 Hereditary Gynecologic and Breast Cancer, International Meeting sponsored by Creighton University, Omaha, Nebraska, June 1985, 20, 246 New Certifications by American Board of Obstetrics and Gynecology, Subspecialty of Oncology, 21, 134 Postgraduate Course in Gynecologic and Obstetric Pathology, Harvard Medical School, April 1985, 20, 136 Second International Symposium on Surgery and Biology of Greater Omentum, Royal Society of Medicine, London, April 1986, 22, 383
Seventh Practical Course in Colposcopy and Cervico-Vaginal Histopathology (in English), Paris, September 1985,21,260 Symposium on Exploring the Future of Cancer Care, sponsored by University of Southern California, Pasadena, April 1985, 20, 408 Third Terry Fox Cancer Conference on Cancer Prevention: Theory and Practice, Vancouver, August 1985, 20, 136 Antibodies dissociation from immune complexes extracted
I Boldface numbers indicate appropriate volume; lightface numbers indicate pagination. 386 0090-8258/8.5 $1.50 Copyright AU rights
0 1985 by Academic Press, Inc. of reproduction in any form reserved.
387
SUBJECT INDEX
from ovarian carcinoma ascitic fluid, analysis, 20, 100; erratum, 22, 382 Antigens cancer antigen 125 and carcinoembryonic antigen, ovarian cancer markers, longitudinal study, 21, 1 elevated serum levels prior to epithelial ovarian carcinoma diagnosis, case report, 22, 115 chlamydial and herpesvirus, cell-mediated and humoral immune responses in cervical carcinoma patients, 20, 184 dissociation from immune complexes extracted from ovarian carcinoma ascitic fluid, analysis, 20, 100; erratum, 22, 382 embryonic reactivity with normal placenta, hydatidifonn mole, and gestational choriocarcinoma, comparison, 22, 334 stage-specific, localization in hydatidiform mole, normal placenta, and gestational choriocarcinoma, 20, 71 _ Ascites malignant, cisplatin intraperitoneal administration, clinical pharmacology, 20, 1 ovarian carcinoma, dissociated antibodies and antigens from extracted immune complexes, analysis, 20, 100; erratum, 22, 382 presenting sign in endometrial carcinoma, case reports, 21, 186
Book reviews Carcinoma of the Ovary. H. G. Bender and L. Beck (Eds.), 1983, 20, 245 Silvergirl’s Surgery: The Breast. G. F. Robbins (Ed.), 1984, 22, 381 Brain cerebellar degeneration, paraneoplastic syndrome complication of ovarian cancer, case report and literature review, 21, 240 Bromocriptine cervical carcinoma treatment, phase II trial, 21, 357 C
Cancer, see also specific type cervix lymphatic spread prognosis, and tumor volume and FIG0 classification, relationship, 22, 15 and oral contraceptives, relationship, epidemiologic studies (review), 22, 1 preclinical, diagnosis with colposcopy, cytology, and histology, evaluation, 22, 302 lung, metastatic to ovary, interpretation problems, case reports, 21, 337 ovary advanced cisplatin, 5-fluorouracil, and methotrexate combination chemotherapy after debulking surgery, evaluation, 20, 290 medroxyprogesterone acetate treatment, B phase II trial, 22, 313 and recurrent, treatment with cyclophosBiopsy phamide, hexamethylmelamine, and 5transperineal fine needle, gynecological tumors fluorouracil combination therapy, 20,23 guided by transrectal ultrasound, 22, 281 resistant to chlorambucil and c&platinum, Bleomycin treatment with cyclophosphamide, and actinomycin-D and vinblastine modified Adriamycin, and c&platinum, 21, 215 combination therapy, advanced and recarcinoembryonic antigen and cancer antigen current endodennal sinus tumor patients, 125 levels, longitudinal study, 21, 1 disease behavior and survival rate, differences 20, 336 in various Israeli ethnic groups, 21, 155 and cisplatin epidemiologic trends in heterogeneous popand mitomycinC and vincristine combination ulation, 21, 287 therapy, gynecological squamous cell human cell line Ia 288: characterization, decarcinoma patients, 20, 387 velopment, and growth properties, 20, and vinblastine combination therapy, ovarian endodermal sinus tumor treatment, 20, 92 with paraneoplastic syndrome of cerebellar 162 and methotrexate and cis-platinum combination degeneration, case report and literature review, 21, 240 therapy prior to radiotherapy, effective 2-P-~ribofuranosylthiazole-4-carboxamide treatment of advanced vaginal carcinoma, treatment in murine subrenal capsule case report, 21, 101
388
SUBJECT INDEX
xenograft assay, 21, 351 pelvis, fractured ureteral catheters, case reports, 22, 356 Carbon dioxide laser treatment cervical intraepithelial neoplasia patients case reports, 21, 331; 22, 46 and cryotherapy, comparative efficacy and side effects, 22, 23 Carcinoma, see also specijic type anaplastic, microfocus, coexisting with sarcomalike mural nodules in mutinous ovarian tumor, case report, 20, 219 cervix bromocriptine treatment, phase II trial, 21, 356 combined radiation therapy and radical hysterectomy, complications in patients, 22, 273 epidemiologic patterns, 1926-1%9 and 19701974, comparison, 20, 378 identification of monocyte chemotaxis inhibitor in plasma of untreated patients, 20, 170 invasive, cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens, 20, 184 secondary, metastasis from ovary, colposcopic diagnosis, case report, 21, 124 skeletal metastases, distribution and correlation to clinical stages, 20, 307 squamous cell primary chemotherapy and postoperative adjuvant chemotherapy, case reports, 22, 59 recurrent, presenting as small bowel obstruction, case report, 22, 109 refractory, continuous-infusion vinblastine, phase II trial, 21, 211 Stage IB, pelvic lymph node T-cell proliferative responsiveness, 20, 177 vulvar lymphangioma circumscriptum complication after treatment, case report, 22, 363
Stage IB and IIA, effect of postoperative external radiotherapy, 22, 73 Stage IV, treatment problems, 21, 42 vaginal recurrence after Okabayashi’s radical hysterectomy, case studies, 20, 10 endometrium ascites as presenting sign, case reports, 21, 186 clinically confined to uterus, extrauterine spread, correlation with risk variables, 21, 23
medroxyprogesterone
acetate
high-dose
treatment, effect on fatty acid composition of serum lecithin and cholesterol ester, 22, 317 cauda equina metastatic, secondary compression: neurologic function preservation and survival after surgical decompression and radiotherapy, case report and literature review, 20, 109 peritoneal metastasis, open-field external beam abdominal radiotherapy, 21, 80 plasminogen activator secretion in vitro, indication of tumor aggressiveness, evaluation, 22, 97 premenopausal women, clinicopathological case review, 20, 298 primary Stage I, treatment with hydroxyprogesterone caproate therapy without surgery and radiation therapy, 20, 139 risk factors, epidemiologic and clinical logistic regression analysis, 21, 228; erratum, 22, 133 and second primary malignancy, case reports, 22, 40
Stage I preoperative cesium treatment, evaluation, 20, 325
surgical treatment only, evaluation, 22, 51 Stages Ia and Ib, separate treatment regimes, evaluation, 22, 294 steroid receptor content and response to medroxyprogesterone acetate treatment, correlation, 21, 314 gynecologic, squamous cell: bleomycin, cisplatin, mitomycin-C, and vincristine combination chemotherapy, 20, 387 ovary advanced, cytoreductive surgery: morbidity and mortality assessment, 20, 190 ascitic fluid, dissociated antibodies and antigens from extracted immune complexes, analysis, 20, 100; erratum, 22, 382 ascites and pleural ehitsions, rapid distribution of Adriamycin, 21, 65 embryonal, and endodermal sinus tumors in children under 15 years, clinicopathological case review, 21, 7 endometrioid cis-dichlorodiammine platinum therapy, inappropriate antidiuretic hormone secretion syndrome, case report, 21, 103 pregnancy-related, case report, 21, 364 epithelial, prediagnostic measurement of serum cancer antigen 125 levels, case report, 22, 115 metastatic to cervix, colposcopic diagnosis,
SUBJECT
case report, 21, 124 minimal residual at second-look surgical reassessment, whole abdominal and pelvic irradiation treatment, 20, 271 &-platinum-based combination chemotherapy, antiemetic efficacy of high-dose metoclopramide, 21, 18 recurrent: retreatment with Cytoxan, hexamethylmelamine, Adriamycin, and cisdiamminedichloroplatinum combination therapy after initial complete response to therapy, 21, 167 treatment with Adriamycin, cyclophosphamide, and cis-platinum combination therapy: effect on cervical and vaginal cytology, 20, 78 ’ tumor marker: serum-mediated immunosuppression, 21, 94 vagina advanced squamous: effective treatment with bleomycin, methotrexate, and cis-platinum combination therapy prior to radiotherapy, case report, 21, 101 primary, radiotherapy: various therapy schemes and modes of application, evaluation, 21, 87 primary squamous cell: treatment, complications, and long-term follow-up, 28, 346 recurrent, after Okabayashi’s radical hysterectomy for cervical carcinoma, case studies, 20, 10 vulva advanced, post-radiotherapy lymphangiosarcoma of edematous thigh, case report, 20, 394 with bone metastasis, case reports, 20, 156 neuroendocrine Merkel cell, case report and literature review, 22, 367 prognostic factors: inguinal node status, vascular invasion, and depth of invasion, 20, 364 radical vulvectomy and bilateral groin lymphadenectomy using separate groin incisions, disease recurrence in intervening skin bridge, case report, 21,247 squamous cell metastases, predictive factors, 21, 196 prognostic parameters, evaluation, 22,341 Catheters right atrial, simplified method for insertion, 21, 207 ureteral, fractured, pelvic cancer patients, case reports, 22, 356 CAT scan, see Tomography
INDEX
389
Cauda equina compression secondary to me&static endometrial carcinoma, neurologic function preservation and survival after surgical &compression and radiotherapy, case report and literature review, 20, 109 Cell lines human choriocarcinoma development of methotrexate-resistant subline, 21, 46 invasive potential and role of lytic enzymes, 22, 324 human ovarian cancer (Ia 288), cloned without agar in vitro: characterization, development, and growth properties, 20, 92 human ovarian tumor (OVA-2), heterotransplantation into nude mice, application to treatment of donor patient, 21, 320 Cervical cancer lymphatic spread prognosis, and tumor volume and FIG0 classification, relationship, 22. 15 and oral contraceptives, relationship, epidemiologic studies (review), 22, 1 preclinical: diagnosis with colposcopy, cytology, and histology, evaluation, 22, 302 Cervical carcinoma bromocriptine treatment, phase II trial, 21,356 combined radiation therapy and radical hysterectomy, complications, case reports, 22, 273 epidemiologic patterns, 1926-1969 and 19701974, comparison, 20, 378 identification of monocyte chemotaxis inhibitor in plasma of untreated patients, 20, 170 invasive, cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens, 20, 184 Okabayashi’s radical hysterectomy, subsequent vaginal recurrence, case studies, 20, 10 secondary, metastasis from ovary, colposcopic diagnosis, case report, 21, 124 skeletal metastases, distribution and correlation to clinical stages, 20, 307 squamous cell primary chemotherapy and postoperative adjuvant chemotherapy, case reports, 22, 59 recurrent, presenting as small bowel obstruction, case report, 22, 109 refractory, continuous-infusion vinblastine, phase II trial, 21, 211 Stage IB, pelvic lymph node T-cell proliferative responsiveness, 20, 177
390
SUBJECT INDEX
vulvar lymphangioma circumscriptum comand methotrexate and cis-platinum: prior to plication after treatment, case report, 22, radiotherapy, effective treatment of ad363 vanced vaginal carcinoma, case report, Stage IB and IIA, effect of postoperative ex21, 101 ternal radiotherapy, 22, 73 bromocriptine phase II trial, cervical carcinoma Stage IV, treatment problems, 21, 42 patients, 21, 356 Cerviscope cisplatin, 5-fluorouracil, and methotrexate: adas mass screening tool for high-risk populations, vanced ovarian cancer patients after deevaluation, 20, 17 bulking surgery, evaluation, 20, 290 Cervix cyclophosphamide, hexamethylmelamine, and dysplasia, mild or moderate: topical vaginal Nluorouracil: advanced and recurrent retinyl acetate gel administration, phase ovarian cancer, therapeutic results and I-II clinical trial, 20, 109 toxicity, 20, 23 glial polyp, immunoperoxidase location of glial cis-dichlorodiammine platinum, ovarian carfibrillary acidic protein, case report, 21, cinoma patient, inappropriate antidiuretic 385 hormone secretion syndrome, case reintraepithelial neoplasia port, 21, 103 carbon dioxide laser treatment, case reports, experimental, human ovarian tumor line het21, 331; 22, 46 erotransplanted into nude mice, applicell-mediated and humoral immune responses cation to treatment of donor patient, 21, to chlamdial and herpesvims antigens, 320 20, 184 c&platinum cryotherapy and laser vaporization treatment, -based combination, antiemetic efficacy of comparative efficacy and side effects, high-dose metoclopramide, 21, 18 -induced emesis, reduction with methylpred22, 23 stromal sarcoma confined to polyp, case report, nisolone and/or metoclopramide, com22, 10s parison, 21, 306 Cesium primary therapy and postoperative adjuvant preoperative, Stage I endometrial carcinoma therapy, squamous cell cervical carcipatients, evaluation, 20, 325 noma patients, case reports, 22, 59 and radiotherapy, recurrent ovarian mixed meChemotherapy sodermal sarcoma, case report, 22, 129 actinomycin-D, bleomycin, and vinblastine: 2-p-n-ribofuranosylthiazole-4-carboxamide acadvanced and recurrent ovarian endotion against human ovarian cancers in dermal sinus tumor patients, 20, 336 murine subrenal capsule xenograft assay, adjuvant, and/or postoperative adjuvant radio21, 351 therapy, evaluation in treatment of uterChlamydia trachomatis ine sarcomas, 20, 281 antigens, cell-mediated and humoral immune Adriamycin responses in cervical carcinoma patients, and cyclophosphamide and &-platinum 20, 184 advanced ovarian cancer patients resistant to chlorambucil and c&platinum treat- Chlorambucil ment, 21, 215 and cis-platinum combination therapy, resistant ovarian carcinoma patients, effect on advanced ovarian cancer patients, subcervical and vaginal cytology, 20, 78 sequent treatment with cyclophosphaand Cytoxan, cis-diamminedichloroplatinum, mide, Adriamycin, and cis-platinum, 21, and hexamethylmelamine: retreatment of 215 recurrent ovarian carcinoma after initial Choriocarcinoma complete response to therapy, 21, 167 colonic pseudoobstruction, evaluation and rapid distribution in ascitic and pleural fluid nonsurgical management, case report, 20, of ovarian carcinoma patients, 21, 65 402 bleomycin gestational and cisplatin, mitomycin-C, and vincristine: localization of stage-specific embryonic angynecological squamous cell carcinoma tigens, comparison with hydatidiform patients, 20, 387 mole and normal placenta, 20, 71
391
SUBJECT INDEX
and normal placenta and hydatidiform mole: reactivity to anti-human sperm monoclonal antibodies, comparison, 22, 334 human cell line development of methotrexate-resistant subline, 21, 46 invasive potential and role of lytic enzymes, 22, 324 Cisplatin and Adriamycin, Cytoxan, and hexamethylmelamine combination therapy: retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 and bleomycin and mitomycin-C and vincristine combination therapy, gynecological squamous cell carcinoma patients, 20, 387 and vinblastine combination therapy, ovarian endodermal sinus tumor treatment, 20, 162 and 5-fluorouracil and methotrexate combination therapy, advanced ovarian cancer patients after debulking surgery, 20, 290 intraperitoneal administration to patients with malignant ascites, clinical pharmacology, 20, 1 Collagenase role in invasive potential of human choriocarcinema cell lines, 22, 324 colposcopy diagnosis of ovarian carcinoma metastatic to cervic, case report, 21, 124 diagnostic value, preclinical cervical cancer patients, 22, 302 diethylstilbestrol-exposed young women, pathologic correlation, 21, 277 procedures for postmenopausal women, 20,62 Cryotherapy and laser vaporization, comparative efficacy and side effects, cervical intraepithelial neoplasia patients, 22, 23 Cyclophosphamide and Adriamycin and cis-diamminedichloroplatinum and hexamethylmelamine combination therapy, retreatment of recurrent ovarian carcinoma after initial complete response to therapy, 21, 167 and c&platinum combination therapy advanced ovarian cancer patients resistant to chlorambucil and cis-platinum, 21,215 effect on cervical and vaginal cytology, 20, 78
and hexamethylmelamine and Sfluorouracil combination therapy, advanced or recurrent ovarian cancer patients, therapeutic results and toxicity, 20, 23 Cytology cervical and vaginal, ovarian carcinoma patients: effect of Adriamycin, cyclophosphamide, and c&platinum combination therapy, 20, 78 diagnostic value, preclinical cervical cancer patients, 22, 302 Cytoxan, see Cyclophosphamide D
Dactinomycin and bleomycin and vinblastine modified combination therapy, advanced and recurrent endodermal sinus tumor patients, 20, 336 DES, see Diethylstilbestrol cis-Diamminedichloroplatinum, see Cisplatin cis-Dichlorodiammine platinum therapy for ovarian carcinoma patient, inappropriate antidiuretic hormone secretion syndrome, case report, 21, 103 Diethylstilbestrol -exposed young women, pathology of colposcopic findings, 21, 277 7,12-Dimethylbenzhrlanthracene, see 9,10-Dimethyl-l ,2-benzanthracene 9, IO-Dimethyl- 1,Zbenzanthracene -induced ovarian tumors in rats by direct application, 21, 54 Doxorubicin, see Adriamycin Dysgerminoma pure, with elevated serum human chorionic gonadotropin levels, case report and literature review, 20, 234 serum lactic dehydrogenase levels and isoenzyme analysis, prognostic value, 22, 65 Dysplasia cervix, mild or moderate: topical vaginal retinyl acetate gel administration, phase I-II clinical trial, 20, 109 E
Emesis c&platinum-induced, reduction with methylprednisolone and/or metoclopramide, comparison, 21, 306 Endometrial adenocarcinoma with coexisting immature teratoma complicated
392
SUBJECT INDEX
by gliomatosis peritonei, case report, 21, 106 Endometrial carcinoma ascites as presenting sign, case reports, 21, 186 chicalIy confined to uterus, extrauterine spread, correlation with risk variables, 21, 23 medroxyprogesterone acetate high-dose treatment, effect on fatty acid composition of serum lecithin and cholesterol ester, 22, 317 metastatic, secondary cauda equina compression: neurologic function preservation and survival after surgical decompression and radiotherapy, case report and literature review, 20, 109 peritoneal metastasis, open-field external beam abdominal radiotherapy, 21, 80 plasminogen activator secretion in vitro: indication of tumor aggressiveness, evaluation, 22, 97 premenopausal women, clinicopathological case review, 20, 298 primary Stage I, treatment with hydroxyprogesterone caproate therapy without surgery and radiation therapy, 20, 139 risk factors, epidemiologic and clinical logistic regression analysis, 21, 228; erratum, 22, 133 and second primary malignancy, case reports, 22, 40 Stage I preoperative cesium treatment, evaluation, 20, 325 surgical treatment only, evaluation, 22, 51 Stages Ia and Ib, separate treatment regimes, evaluation, 22, 294 steroid receptor content and response to medroxyprogesterone acetate treatment, correlation, 21, 314 Endometrial sarcoma association with ovarian thecoma, polycystic ovarian disease, and prolonged estrogen therapy, 21, 135 Estradiol-17/3 effect on myometrium and leiomyoma cultured smooth muscle cell differentiation, ultrastructural analysis, 21, 32 Estrogen elevated serum levels, ovarian Sertoli cell tumor patient, case report, 22, 85 precolposcopic administration for postmenopausal women, 20, 62 prolonged therapy, and ovarian thecoma and polycystic ovarian disease: association with endometrial sarcomas, 21, 135
Estrogen receptors nuclear, high levels in solitary pelvic neural tumors, case reports, 20, 43 identification in recurrent and metastatic endolymphatic stromal myosis patient with good response to progestin therapy, case report, 20, 120 tumor content, and response to medroxyprogesterone acetate treatment, correlation, endometrial carcinoma patients, 21,314 Ethnicity population differences in ovarian cancer in Israel, 21, 155, 287 F
Fallopian tube prolapse, misdiagnosis as vaginal adenocarcinoma in postmenopausal patient, case report, 21, 369 Fatty acids in serum lecithin and cholesterol ester, effect of high-dose medroxyprogesterone acetate, endometrial carcinoma patients, 22, 317 o-Fetoprotein in ovarian immature teratoma, heterogenous origin, immunocytochemical evidence, 21, 73
FIG0 classification role in prognosis of lymphatic spread from cervical cancer, comparison with tumor volume, 22, 15 Fistulae ureterovaginal, after radical hysterectomy, effect of internal iliac artery ligation, 21, 359 5-Fluorouracil and cisplatin and methotrexate combination therapy, advanced ovarian cancer patients after debulking surgery, 20, 290 and cyclophosphamide and hexamethylmelamine combination therapy, advanced or recurrent ovarian cancer patients, therapeutic results and toxicity, 20, 23 Formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide -induced ovarian tumors in rats by direct application, 21, 54 G Gastrointestinal tract site of recurrent squamous cell cervical carcmoma, case report, 22, 109
SUBJECT
Glioma in cervix, immunoperoxidase location of glial fibrillary acidic protein, case report, 21, 385 Gliomatosis peritonei complication in coexistent immature teratoma and endometrial adenocarcinoma, case report, 21, 106 Gonadotropin human chorionic, see Human chorionic gonadotropin H
Hemangiopericytoma vaginal, light and electron microscopy, case report, 21, 376 Herpes simplex virus antigens, cell-mediated and humoral immune responses in cervical carcinoma patients, 20, 184 Hexamethylmelamine, see Altretamine Histology diagnostic value, preclinical cervical cancer patients, 22, 302 Hormones, see also specific hormones antidiuretic, inappropriate secretion syndrome during cis-dichlorodiammine platinum therapy, ovarian carcinoma patient, case report, 21, 103 Human chorionic gonadotropin P-subunit, elevated serum levels in association with pure dysgenninoma, case report and literature review, 20, 234 Hydatidiform mole and gestational choriocarcinoma and normal placenta, reactivity to anti-human sperm monoclonal antibodies, comparison, 22, 334
localization of stage-specific embryonic antigens, comparison with normal placenta and gestational choriocarcinoma, 20, 71 Hydroxyprogesterone caproate treatment for primary endometrial carcinoma Stage I, 20, 139 Hysterectomy Okabayashi’s radical, cervical carcinoma treatment, subsequent vaginal recurrence, case studies, 20, 10 radical with lymph node dissection, lower urinary tract changes: dynamic videourethrocystography and simultaneous urethrocystometry, 21, 261
393
INDEX
postoperative ureterovaginal fistula, effect of internal iliac artery ligation, 21, 359 and radiation therapy, cervical carcinoma patients, complications, case reports, 22, 273
Immune responses cell-mediated and humoral, to chlamydial and herpesvirus antigens, cervical carcinoma patients, 20, 184 Immunosuppression normal in vitro T-cell proliferation and natural killer cell activity, by serum from ovarian carcinoma patients, 21, 94 Intestinal obstruction colonic pseudoobstruction, choriocarcinoma patient, evaluation and nonsurgical management, case report, 20, 402 Irradiation -induced adenocarcinoma in cecal neovagina, case report and literature review, 21, 235
whole abdominal and pelvic, ovarian carcinoma patients with minimal residual disease at second-look surgical reassessment, 20, 271 K
Keratoacanthoma vulva, case report, 21, 118 L
Lactic dehydrogenase serum levels and isoenzyme analysis: ovarian tumor marker, evaluation, 22, 65 Leiomyosarcoma uterine, clinicopathologic case studies, 21, 220 Lung cancer metastatic to ovary, interpretation problems, case reports, 21, 337 Lymphangioma circumscriptum vulvar, post-treatment complication, squamous cell cervical carcinoma patient, case report, 22, 363 Lymphangiosarcoma edematous thigh, post-radiotherapy development in vulvar carcinoma patient, case report, 20, 394 Lymph node pelvic, cervical squamous cell carcinoma pa-
394
SUBJECT
tients, T-cell proliferative responsiveness, 20, 177 Lymphocytes T-cell proliferation and natural killer cell activity in vitro, suppressive effect of serum from ovarian carcinoma patients, 21, 94 M
Malignancies, see also specific types gynecologic, surgical technique for abdominal retroperitoneum exploration, 22, 32 multiple primaries, endometrial carcinoma patients, case reports, 22, 40 ovary, treatment with intraperitoneal phosphorus-32, safety and morbidity evaluation, 21, 294 Medroxyprogesterone acetate advanced ovarian cancer treatment, phase II trial, 22, 313 effect on plasminogen activator activity in human endometrial carcinoma explants, 22, 97 endometrial carcinoma patient response, correlation with steroid receptor content, 21, 314 high-dose, effect on fatty acid composition of serum lecithin and cholesterol ester in endometrial carcinoma patients, 22, 317 Merkel cell carcinoma vulva, case report and literature review, 22, 367 Metastasis bony from cervical carcinoma, distribution and correlation to clinical stages, 20, 307 from vulvar carcinoma, case reports, 20, 156 brain, from advanced ovarian adenocarcinoma: spontaneous intracranial hemorrhage, case report, 20, 204 cervical, from ovarian carcinoma, colposcopic diagnosis, case report, 21, 124 inguinal, from vulva squamous cell carcinoma, predictive factors, 21, 196 lymphatic, and tumor volume and FIG0 classification, relationship in cervical cancer prognosis, 22, 15 ovarian, from lung cancer, interpretation problems, case reports, 21, 337 peritoneal, from endometrial carcinoma patients, open-field external beam abdominal radiotherapy, 21, 80 placental-site trophoblastic tumor: failure of chemotherapy, surgery, and radiotherapy, case report, 21, 111
INDEX
renal, from malignant gestational trophoblastic disease, use of intravenous urography in staging, 20, 317 Methotrexate and bleomycin and &-platinum combination therapy prior to radiotherapy, effective treatment of advanced vaginal carcinoma, case report, 21, 101 and cisplatin and Sfluorouracil combination therapy, advanced ovarian cancer patients after debulking surgery, 20, 290 -resistant human choriocarcinoma cell line, development, 21, 46 N-Methyl-N’nitrosourea -induced ovarian tumors in rats by direct application, 21, 54 Methylprednisolone and/or metoclopramide, comparative efficacy in reduction of cis-platinum-induced emesis, 21, 306 Metoclopramide high-dose, antiemetic in patients receiving cisplatinum-based combination chemotherapy, 21, 18 and/or methylprenisolone, comparative efficacy in reduction of c&platinum-induced emesis, 21, 306 Mitomycin C and bleomycin, cisplatin, and vincristine combination therapy, gynecological squamous cell carcinoma patients, 20, 387 Monocytes chemotaxis, inhibitor identification in plasma of untreated cervical carcinoma patients, 20, 170 Morphine postoperative pain relief, continuous intravenous infusion and intramuscular injections, comparison, 22, 288 Myoblastoma granular cell, vulvar involvement, case reports, 22, 352 N
Neoplasia intraepithelial cervix carbon dioxide laser treatment, case reports, 21, 331; 22, 46 cell-mediated and humoral immune responses to chlamdial and herpesvirus antigens, 20, 184 cryotherapy and laser vaporization treatment, comparative efficacy and side effects, 22, 23
SUBJECT INDEX
395
treatment in murine subrenal capsule xenograft assay, 21, 351 Ovarian carcinoma advanced, cytoreductive surgery, morbidity and mortality assessment, 20, 190 ascites and pleural effisions, rapid distribution of Adriamycin, 21, 65 ascitic fluid, dissociated antibodies and antigens from extracted immune complexes, analysis, 20, 100; erratum, 22, 382 embryo@ and endodermal sinus tumors in children under 15 years, clinicopathological case review, 21, 7 endometrioid cis-dichlorodiammine platinum therapy, inappropriate antidiuretic hormone secreation syndrome, case report, 21, 103 pregnancy-related, case report, 21, 364 epithelial, prediagnostic measurement of serum 0 cancer antigen 125 levels, case report, 22, 115 Oral contraceptives metastatic to cervix, colposcopic diagnosis, case and cervical cancer, relationship, epidemiologic report, 21, 124 studies (review), 22, 1 minimal residual at second-look surgical reasOvarian adenocarcinoma sessment, whole abdominal and pelvic advanced, metastatic to brain: spontaneous inirradiation treatment, 20, 271 tracranial hemorrhage, case report, 20, cis-platinum-based combination chemotherapy, 204 antiemetic efficacy of high-dose metoOvarian cancer clopramide, 21, 18 advanced recurrent, retreatment with Cytoxan, hexacisplatin, Muorouracil, and methotrexate methylmelamine, Adriamycin, and ciscombination chemotherapy after dediamminedichloroplatinum combination bulking surgery, evaluation, 20, 290 therapy after initial complete response medroxyprogesterone acetate treatment, to therapy, 21, 167 phase II trial, 22, 313 treatment with Adriamycin, cyclophosphamide, and recurrent, treatment with cyclophosand cis-platinum combination therapy: phamide, hexamethylmelamine, and 5effect on cervical and vaginal cytology, fluorouracil combination therapy, 20,23 20, 78 tumor marker: serum-mediated immunoresistant to chlorambucil and cis-platinum, with treatment cyclophosphamide, suppression, 21, 94 Adriamycin, and c&platinum, 21, 215 ovary carcinoembryonic antigen and cancer antigen bilateral teratomas, coexistence with sclerosing 125 levels, longitudinal study, 21, 1 stromal tumor, case report, 21, 252 disease behavior and survival rate, differences dysgerminoma in various Israeli ethnic groups, 21, 155 elevated serum human chorionic gonadotropin epidemiologic trends in heterogeneous populevels, case report and literature review, lation, 21, 287 20, 234 human cell line Ia 288: characterization, deserum lactic dehydrogenase levels and isovelopment, and growth properties, 20, enzyme analysis, prognostic value, 22, 65 92 endodermal sinus tumor with paraneoplastic syndrome of cerebellar deadvanced and recurrent: modified vinblastine, generation, case report and literature review, 21, 240 actinomycin-D, and bleomycin combi2-p-u-ribofuranosylthiazole-4-carboxamide nation therapy, 20, 336 vulva, treatment by local excision and colposcopy efficacy, retrospective evaluation, 21, 300 Neoplasms, see also specific neoplasms endolymphatic stromal myosis, recurrent and metastatic: positive estrogen and progesterone receptors and good response to progestin therapy, case report, 20, 120 epithelial ovarian, of low malignant potential, case reports, 21, 177 Neovagina cecal, radiation-induced adenocarcinoma, case report and literature review, 21, 235 Nodules mural, sarcoma-like, coexisting with microfocus of anaplastic carcinoma in mutinous ovarian tumor, case report, 20, 219
396
SUBJECT INDEX
treatment with cisplatin, vinblastine, and localization of stage-specific embryonic antigens, comparison with hydatidiform bleomycin combination therapy, 20, 162 mole and gestational choriocarcinoma, epitheliti neoplasms of low malignant potential, 20, 71 case reports, 21, 177 immature teratoma, heterogenous origin of o- Plasma monocyte chemotaxis inhibitor, identification fetoprotein, immunocytochemical eviin untreated cervical carcinoma patients, dence, 21, 73 malignancies, treatment with intraperitoneal 20, 170 Plasminogen activator phosphorus-32, safety and morbidity secretion by human endometrial carcinoma exevaluation, 21, 294 mixed mesodermal sarcoma, recurrent, survival plants: indication of tumor aggressiveafter combination radiotherapy and ness, evaluation, 22, 97 &-Platinum chemotherapy, 22, 129 and Adriamycin and cyclophosphamide comthecoma, polycystic disease, and prolonged esbination therapy trogen therapy: association with endoadvanced ovarian cancer patients resistant metrial sarcomas, 21, 135 tumors to chlorambucil and &-platinum, 21, 215 effect on cervical and vaginal cytology, 20, cell line OVA-2, heterotransplantation into 78 nude mice, application to treatment of -based combination chemotherapy, antiemetic donor patient, 21, 320 chemical induction in rats, 21, 54 efficacy of high-dose metoclopramide in patients with advanced malignancies, 21, metastatic, from lung cancer, interpretation 18 problems, case reports, 21, 337 and bleomycin and methotrexate combination mutinous, with sarcoma-like mural nodules therapy prior to radiotherapy, effective coexisting with microfocus of anaplastic treatment of advanced vaginal carcinoma, carcinoma, case report, 20, 219 case report, 21, 101 Sertoli cell, elevated serum estrogen and -induced emesis, reduction with methylpredprogesterone levels, case report, 22, 85 nisolone and/or metoclopramide, comstrumal carcinoid, with amyloid stroma, case parison, 21, 306 report and 20-year follow-up, 22, 121 primary chemotherapy and postoperative adjuvant chemotherapy, squamous cell P cervical carcinoma patients, case reports, 22, 59 Paraneoplastic syndrome Polycystic ovarian disease cerebellar degeneration, ovarian cancer patient, and ovarian thecoma and prolonged estrogen case report and literature review, 21, therapy, association with endometrial 240 sarcomas, 21, 135 Pelvic cancer Pregnancy fractured ureteral catheters, case reports, 22, -related ovarian endometrioid carcinoma, case 356 report, 21, 364 Pelvis Progesterone solitary benign neural tumors with high steroid effect on myometrium and leiomyoma cultured receptor content, case reports, 20, 43 smooth muscle cell differentiation, ulPhosphorus-32 trastructural analysis, 21, 32 intraperitoneal instillation, ovarian malignancy elevated serum levels, ovarian Sertoli cell tumor treatment, safety and morbidity evalupatient, case report, 22, 85 ation, 21, 294 Progesterone receptors Placenta identification in recurrent and metastatic ennormal dolymphatic stromal myosis patient with and gestational choriocarcinoma and hydagood response to progestin therapy, case tidiform mole: reactivity to anti-human report, 20, 120 sperm monoclonal antibodies, compartumor content, and response to medroxyproison, 22, 334 gesterone acetate treatment, correlation,
SUBJECT INDEX endometrial carcinoma patients, 21, 314 Progestin receptors cytoplasmic and nuclear, high levels in solitary pelvic neural tumors, case reports, 20, 43 Progestin therapy, see also Medroxyprogesterone acetate recurrent and metastatic endolymphatic stromal myosis patient with good response, case report, 20, 120 Proteins glial fibrillary acidic, immunoperoxidase location in cervical glial polyp, case report, 21, 385
397
action against untreated human ovarian cancers in murine subrenal capsule xenograft assay, 21, 351
S
Sarcoma dermatofibrosarcoma protuberans, vulva, case report, 20, 129 endometrial, association with ovarian thecoma, polycystic ovarian disease, and prolonged estrogen therapy, 21, 135 leiomyosarcoma, see Leiomyosarcoma -like mural nodules, coexisting with microfocus of anaplastic carcinoma in mutinous R ovarian tumor, case report, 20, 219 mixed mesodenual, ovarian, recurrent: survival after combination radiotherapy and Radiation therapy, see Radiotherapy chemotherapy, 22, 129 Radiotherapy stromal, in cervical polyp, case report, 22, 105 abdominal, open-field external beam, endometrial carcinoma patients with peritouterine adjuvant radiotherapy and/or chemotherapy, neal metastases, 21, 80 evaluation, 20, 281 and chemotherapy, recurrent ovarian mixed epidemiology and clinical course, Israeli 7mesodermal sarcoma, case report, 22, year study, 20, 354; letter to editor, 22, 129 379 with intraperitoneal phosphorus-32, safety and Sertoli cell tumor morbidity evaluation, ovarian malignancy ovarian, elevated serum estrogen and progespatients, 21, 294 terone levels, case report, 22, 85 postoperative Stein-Leventhal syndrome, see Polycystic ovarian adjuvant, and/or adjuvant chemotherapy, disease evaluation in treatment of uterine sarSurgery comas, 20, 281 abdominal retroperitoneum exploration techeffect on cervical carcinoma Stage IB and nique, use in staging of gynecologic maIIA, 22, 73 and radical hysterectomy, cervical carcinoma lignancy patients, 22, 32 patients, complications, case reports, 22, cytoreductive, advanced ovarian carcinoma patients, morbidity and mortality as273 various therapy schemes and modes of applisessment, 20, 190 cation, effect on remission rates for prihysterectomy, see Hysterectomy mary vaginal carcinoma patients, 21, 87 ligation of internal iliac artery during radical and vertebrectomy for cauda equina compreshysterectomy, effect on urinary tract fission secondary to metastatic endometrial tula formation, 21, 359 carcinoma, neurologic function preserpostoperative pain relief with morphine, continuous intravenous infusion and intravation and survival, case report and litmuscular injections, comparison, 22,288 erature review, 20, 209 vulvar carcinoma patient, post-treatment deradical vulvectomy and bilateral groin lymphadenectomy using separate groin incivelopment of lymphangiosarcoma of sions, vulvar carcinoma recurrence in edematous thigh, case report, 20, 394 Retinyl acetate intervening skin bridge, case report, 21, gel, topical vaginal administration to mild or 247 moderate cervical dysplasia patients, Stage I endometrial carcinoma treatment, comparison with combined surgery and irphase I-II clinical trial, 20, 109 2-fl-r&ibofuranosylthiazole-4-carboxamide radiation therapy, 22, 51
398
SUBJECT INDEX
vertebrectomy for cauda equina compression secondary to metastatic endometrial carcinoma, neurologic function preservation and survival, case report and literature review, 20, 209 T
T cells pelvic lymph node, isolated from cervical squamous cell carcinoma patients: numbers and reactivities, 20, 177 Teratoma bilateral, ovarian, coexistence with sclerosing stromal tumor, case report, 21, 252 immature coexistence with endometrial adenocarcinoma complicated by gliomatosis peritonei, case report, 21, 106 ovarian, heterogenous origin of a-fetoprotein, immunocytochemical evidence, 21, 73 Thrombosis deep venous, prevention with Venodyne or leg compressors, letter to editor, 21, 133 Tiazofurin, see 2-p-o-Ribofuranosylthiazole-4carboxamide Tomography computed, and ultrasonography, use in primary diagnosis of gynecological tumors, 21, 161 Trophoblastic disease gestational late recurrence, case reports, 20, 83 malignant with renal metastases, use of intravenous urography in staging, 20, 317 in women aged 50 or more, case reports, 20, 53 Trophoblasts normal placental, and gestational choriocarcinoma and hydatidiform mole: reactivity to anti-human sperm monoclonal antibodies, comparison, 22, 334 Tumors, see also speciJc tumors endodermal sinus infant vagina, case report, 20, 196 and ovarian embryonal carcinoma, in children under 1.5years, clinicopathological case review, 21, 7 ovary advanced and recurrent: modified vinblastine, actinomycin-D, and bleomycin combination therapy, 20, 336 treatment with cisplatin, vinblastine, and bleomycin combination therapy, 20, 162
gynecologic primary diagnosis by ultrasonography and computed tomography, 21, 161 transperineal fine needle biopsy guided by transrectal ultrasound, 22, 281 hemangiopericytoma, vaginal, light and electron microscopy, case report, 21, 376 keratoacanthoma, vulvar, case report, 21, 118 leiomyoma, and myometrium cultured smooth muscle cell differentiation, sex steroid effect, ultrastructural analysis, 21, 32 malignancy evaluation by mitotic count, letter to editor, 22, 379 malignant mesodermal mixed, uterus: prognostic factors, surgicopathologic stage, and vascular invasion, 20, 32 neural, solitary benign, pelvis: with high steroid receptor content, case reports, 20, 43 ovarian cell line OVA-2, heterotransplantation into nude mice, application to treatment of donor patient, 21, 320 metastatic from lung cancer, interpretation problems, case reports, 21, 337 chemical induction in rats, 21, 54 mutinous, with sarcoma-like mural nodules coexisting with microfocus of anaplastic carcinoma, case report, 20, 219 strumal carcinoid with amyloid stroma, case report and 20-year follow-up, 22, 121 thecoma, and polycystic ovarian disease and prolonged estrogen therapy: association with endometrial sarcomas, 21, 135 sclerosing stromal, coexistence with bilateral teratomas, case report, 21, 252 trophoblastic pseudotumor, metastatic: failure of chemotherapy, surgery, and radiotherapy, case report, 21, 111 Tumor volume role in prognosis of lymphatic spread from cervical cancer, comparison with pathological staging, 22, 15
U
Ultrasonography and computed tomography, use in primary diagnosis of gynecological tumors, 21, 161 Ultrasound transrectal, -guided transperineal fine needle biopsy of gynecological tumors, 22, 281 Urethrocystography and urethrocystometry, simultaneous urody-
399
SUBJECT INDEX
namic evaluation of lower urinary tract changes after radical hysterectomy with lymph node dissection, 21, 261 Urethrocystometry and urethrocystography, simultanous urodynamic evaluation of lower urinary tract changes after radical hysterectomy with lymph node dissection, 21, 261 Urinary tract fistula formation after radical hysterectomy, effect of internal iliac artery ligation, 21, 3.59
lower, changes after radical hysterectomy with lymph node dissection, dynamic videourethrocystography and simultaneous urethrocystometry, 21, 261 Urography intravenous, use in staging of malignant gestational trophoblastic disease with renal metastases, 20, 317 Uterus cervix, see Cervix coexistent immature teratoma and endometrial adenocarcinoma complicated by gliomatosis peritonei, case report, 21, 106 extrauterine spread in endometrial carcinoma clinically confined to uterus, correlation with risk variables, 21, 23 leiomyoma and myometrium, cultured smooth muscle cell differentiation, sex steroid effect, ultrastructural analysis, 21, 32 leiomyosarcoma, clinicopathologic case studies, 21, 220
malignant mesodermal mixed tumors: prognostic factors, surgicopathologic stage, and vascular invasion, 20, 32 placental-site trophoblastic tumor, metastatic: failure of chemotherapy, surgery, and radiotherapy, case report, 21, 111 sarcoma adjuvant radiotherapy and/or chemotherapy, evaluation, 20, 281 epidemiology and clinical course, Israeli 7year study, 20, 354; letter to editor, 22, 379
V
Vagina, see also Neovagina endodermal sinus tumor, infant, case report, 20, 1% hemangiopericytoma, light and electron mi-
croscopy, case report, 21, 376 Vaginal adenocarcinoma erroneous diagnosis of prolapsed fallopian tube in postmenopausal patient, case report, 21, 369
Vaginal carcinoma advanced squamous, effective treatment with bleomycin, methotrexate, and cis-platinum combination therapy prior to radiotherapy, case report, 21, 101 primary, radiotherapy: various therapy schemes and modes of application, evaluation, 21, a7
recurrent, after Okabayashi’s radical hysterectomy for cervical carcinoma, case studies, 20, 10 squamous cell: treatment, complications, and long-term follow-up, 20, 346 Vinblastine and actinomycin-D and bleomycin modified combination therapy, advanced and recurrent endodermal sinus tumor patients, 20, 336
and bleomycin and cisplatin combination therapy, ovarian endodermal sinus tumor treatment, 20, 162 continuous infusion, refractory cervical squamous cell carcinoma treatment, phase II trial, 21, 211 Vincristine and bleomycin, cisplatin, and mitomycin-C combination therapy, gynecological squamous cell carcinoma patients, 20, 387
Vulva dermatofibrosarcoma protuberans, case report, 20, 129
granular cell myoblastoma, case reports, 22, 352
intraepithelial neoplasia, treatment by local excision and colposcopy efficacy, retrospective evaluation, 21, 300 keratoacanthoma, case report, 21, 118 lymphangioma circumscriptum, post-treatment complication, squamous cell cervical carcinoma patient, case report, 22, 363 neuroendocrine carcinoma, case report and literature review, 22, 367 Vulvar carcinoma advanced, post-radiotherapy lymphangiosarcoma of edematous thigh, case report, 20, 394
with bone metastasis, case reports, 20, 156 prognostic factors: inguinal node status, vascular
400
SUBJECT
invasion, and depth of invasion, 20, 364 radical vulvectomy and bilateral groin lymphadenectomy using separate groin incisions, disease recurrence in intervening
INDEX
skin bridge, case report, 21, 241 squamous cell metastases, predictive factors, 21, 196 prognostic parameters, evaluation, 22, 341